LATERA-OFFICE Study

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

March 21, 2018

Study Completion Date

August 29, 2019

Conditions
Nasal Obstruction
Interventions
DEVICE

Nasal Implant

Latera implant placed as a standalone procedure or in conjunction with a turbinate reduction procedure in an office setting under local anesthesia.

Trial Locations (9)

10016

Madison ENT & Facial Plastic Surgery, New York

30342

ENT of Georgia, Atlanta

33472

The Center for Sinus, Allergy, & Sleep Wellness, Boynton Beach

33487

ENT Assoc. of South Florida, Boca Raton

60602

Chicago Nasal & Sinus Center, Chicago

75034

Collin County ENT, Frisco

84403

Ogden Clinic, Ogden

90210

Beverly Hills Aesthetic Surgical Institute, Beverly Hills

90212

Alessi Institute For Facial Plastic Surgery, Beverly Hills

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

New Arch Consulting

INDUSTRY

lead

Spirox, Inc.

INDUSTRY

NCT02964312 - LATERA-OFFICE Study | Biotech Hunter | Biotech Hunter